# fondaparinux sodium

NDC: 11797-155
Generic name: fondaparinux sodium
Labeler / Manufacturer: Italfarmaco S.p.A
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190206

FDA application: ANDA208615

## Active ingredients

- FONDAPARINUX SODIUM: 5 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11797-155"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11797-155
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58789e3d-e5bc-4c2e-a527-495a252fcecd